2[2]Yamamoto S,Konishi I,Mandai M,et al.Expression of vascular endothelial growth factor(VEGF) in epithelial ovarian neoplasm:Correlation with clinicopathology and patient survival,and analysis of serum VEGF levels[J].Br J Cancer,1997,76:1221-1227. 被引量：1
3[3]Chen CA,Cheng WF,Lee CN,et al.Serum VEGF in epithelial ovarian neoplasms:correlation with patient survival[J].Gynecol oncol,1999,74:235-240. 被引量：1
4[6]Abulafia O,Sherer DM.Angiogenesis of the ovary[J].Am J Obstet Gynecol,2000,18(1):240-246. 被引量：1
5[1]Luo JC, Toyoda M, Shibuya M. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody. Cancer Res,1998,58:2594-600. 被引量：1
6[2]Edgren M, Lennernas B, Larssn A, et al. Serum concentrations of VEGF and b FGF in renal cell, prostate and urinary bladder carcinomas. Anticancer Res, 1999,19:869-873. 被引量：1
7[4]Shimada H, Takeda A, Nabeya Y, et al. Clinical significance of serum VEGF in esophageal squamous cell carcinoma. Cancer,2001,92:663-689. 被引量：1
8[5]Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol, 1992,3:65-71. 被引量：1
9[7]Abu-Jawdeh GM, Faix JD, Niloff J, et al. Strong expression of vascular permeability factor and its receptors in ovarian borderline and malignant neoplasms. Lab Invest,1996,74:1105-1115. 被引量：1
10[9]Chen CA, Cheng WF, Lee CN, et al. Serum VEGF in epithelial ovarian neoplasms: correlation with patient survival. Gynecol Oncol, 1999,74: 235-240. 被引量：1
